MedPlus Health Services Limited has announced its unaudited consolidated financial results for the quarter and half-year ended September 30, 2026. The company reported a revenue from operations of ₹20,371.08 million for the quarter and ₹39,167.08 million for the half-year. Net profit after tax for the quarter stood at ₹560.69 million, while for the half-year, it was ₹892.36 million. The results also include the allotment of 19,095 equity shares under the MedPlus Employees Stock Option Plan, 2021.
MedPlus Health Announces Q2 FY27 Financial Results
MedPlus Health Services Limited has published its unaudited consolidated financial results for the second quarter and the first half of the financial year ending September 30, 2026. The company’s revenue from operations for the quarter reached ₹20,371.08 million, a notable increase from the previous year. For the half-year ended September 30, 2026, total revenue from operations amounted to ₹39,167.08 million.
Key Financial Highlights
The company reported a net profit after tax of ₹560.69 million for the quarter ended September 30, 2026. The profit for the half-year period concluded at ₹892.36 million. Total comprehensive income for the quarter was ₹567.75 million, and for the half-year, it stood at ₹899.42 million.
Employee Stock Option Allotment
In addition to the financial results, MedPlus Health announced the allotment of 19,095 equity shares. These shares were issued under the MedPlus Employees Stock Option Plan, 2021 (‘ESOP, 2021’) to eligible employees of the Company and Group Company. Detailed disclosures related to this allotment, as required by SEBI regulations, will be provided separately.
Website Availability
The financial results and related limited review reports are available on the company’s official website, www.medplusindia.com, as well as on the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com).
Source: BSE
